Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Kneteman

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Flp/<i>FRT</i>-mediated disruption of <i>ptex150</i> and <i>exp2</i> in <i>Plasmodium falciparum</i> sporozoites inhibits liver-stage developmentRobyn McConville, Jelte M M Krol, Ryan W J Steel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 22, 2015
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateDaire O'Shea, John Law, Adrian Egli, et al.
Plos One|May 24, 2013
Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virusYutaka Takebe, Carrie J Saucedo, Garry Lund, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 5, 2003
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-upPaul Greig, Leslie Lilly, Charles Scudamore, et al.
Journal of Virology|August 3, 2012
Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new hostRichard J P Brown, Natalia Hudson, Garrick Wilson, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Flp/<i>FRT</i>-mediated disruption of <i>ptex150</i> and <i>exp2</i> in <i>Plasmodium falciparum</i> sporozoites inhibits liver-stage developmentRobyn McConville, Jelte M M Krol, Ryan W J Steel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 22, 2015
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateDaire O'Shea, John Law, Adrian Egli, et al.
Plos One|May 24, 2013
Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virusYutaka Takebe, Carrie J Saucedo, Garry Lund, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 5, 2003
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-upPaul Greig, Leslie Lilly, Charles Scudamore, et al.
Journal of Virology|August 3, 2012
Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new hostRichard J P Brown, Natalia Hudson, Garrick Wilson, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 4